IBX Imagion Biosystems Limited
—Mkt Cap: —P/E: —1d ago
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medic…
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value3.36M USD
Revenue (TTM)396.15K USD
Gross Profit-1.73M USD
Net Income (TTM)-2.98M USD
Revenue/Share0.0010 AUD
Last Price—
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000IBX6
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-1.19
EV/Revenue8.47
P/S6.99
P/B-0.83
EPS (TTM)-0.01
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin-331.40%
EBITDA Margin0.00%
Profit Margin0.00%
ROE199.33%
ROA-210.82%
Growth
Revenue Growth1943.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.80M USD
CapEx (TTM)—
FCF Margin-525.81%
FCF Yield—
Net Debt1.49M USD
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity-1.19
Current Ratio0.16
Quick Ratio0.15
Book Value/Sh-0.0060 AUD
Cash/Share0.00 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateNov 16, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.801.01M
Float386.07M
Insiders14.81%
Institutions0.00%
Technical
SMA 500.0086 AUD
SMA 2000.0161 AUD
Beta-0.19
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)2.33M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—